Catch-up growth following transfer from three times weekly im to daily sc administration of hGH in GH deficient patients, monitored by knemometry
- PMID: 4013610
- DOI: 10.1530/acta.0.1090163
Catch-up growth following transfer from three times weekly im to daily sc administration of hGH in GH deficient patients, monitored by knemometry
Abstract
A novel and non-invasive technique of growth measurement is introduced. By this method the length of the human lower leg is measured with an accuracy of 0.1 mm. Thus, growth velocities can be estimated within a few weeks. In the present study the immediate changes of growth velocity are demonstrated, following the transfer of growth hormone administration from three times weekly im to daily sc in 9 growth hormone deficient children, age 7.4 to 20.5 years. The first observation period (3 times weekly im administration) ranged from 32 to 72 days, the second observation period (daily sc administration) ranged from 160 to 267 days). During the study, the total weekly dosage of growth hormone remained unchanged (12 IU/m2/week). In all 9 patients growth velocity increased significantly after the transfer of application. Mean growth velocity of the lower leg rose from 0.04 mm/day up to 0.065 mm/day. Mean growth velocity of total body height rose form 4.8 cm/year up to 6.9 cm/year. In addition, differential lower leg growth rates of 3 to 4 week periods were established in all 9 patients, revealing a significant catch-up growth spurt immediately following the transfer of application. During this spurt mean lower leg growth velocity rose form 0.04 mm/day up to 0.091 mm/day. This marked increase of lower leg growth rates lasted for only a few weeks and was followed by a period of decreased growth velocity. On the long run, growth velocity shifted upward in a wave-like pattern, stabilizing on a significantly higher level than before the transfer of application.
Similar articles
-
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.Acta Endocrinol (Copenh). 1983 Oct;104(2):148-52. doi: 10.1530/acta.0.1040148. Acta Endocrinol (Copenh). 1983. PMID: 6637329
-
A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.Endocrinol Jpn. 1988 Jun;35(3):477-84. doi: 10.1507/endocrj1954.35.477. Endocrinol Jpn. 1988. PMID: 3197659
-
GH deficient children receiving GH replacement do not grow during intermittent infectious illness.Acta Paediatr Scand. 1986 Jul;75(4):601-4. doi: 10.1111/j.1651-2227.1986.tb10258.x. Acta Paediatr Scand. 1986. PMID: 3751554
-
The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.Horm Res. 1998;49 Suppl 2:41-57. doi: 10.1159/000053087. Horm Res. 1998. PMID: 9730672 Review.
-
What is the best mode of growth hormone administration?Acta Paediatr Scand Suppl. 1989;362:44-9. doi: 10.1111/j.1651-2227.1989.tb11307.x. Acta Paediatr Scand Suppl. 1989. PMID: 2485598 Review. No abstract available.
Cited by
-
Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.J Clin Endocrinol Metab. 2015 Nov;100(11):4364-71. doi: 10.1210/jc.2014-4146. Epub 2015 Oct 1. J Clin Endocrinol Metab. 2015. PMID: 26425883 Free PMC article. Clinical Trial.
-
Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group.Arch Dis Child. 1995 May;72(5):427-31. doi: 10.1136/adc.72.5.427. Arch Dis Child. 1995. PMID: 7618910 Free PMC article.
-
Methionyl human growth hormone in Turner's syndrome.Arch Dis Child. 1988 Oct;63(10):1211-7. doi: 10.1136/adc.63.10.1211. Arch Dis Child. 1988. PMID: 3196048 Free PMC article.
-
The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.Pharm Res. 1990 May;7(5):547-52. doi: 10.1023/a:1015885204249. Pharm Res. 1990. PMID: 2367323
-
Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.Patient Prefer Adherence. 2011 Mar 10;5:117-24. doi: 10.2147/PPA.S10985. Patient Prefer Adherence. 2011. PMID: 21448295 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical